Holdings of BlackRock Health Sciences Opportunities Portfolio
BlackRock Funds · Original filing · Compare with another fund · Report an error
- Net assets
- 5.9B $ including 5.8B $ in equities, 98.7 %
- Positions
- 133 in 15 countries
- Top ten
- 52.0 % of net assets
- Filed on
- May 29, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 656,650 | 725.6M $ | 12.29 % |
| 2 | Johnson & Johnson | 2,299,215 | 518.1M $ | 8.77 % |
| 3 | UnitedHealth Group Inc | 947,412 | 360.3M $ | 6.10 % |
| 4 | Merck & Co Inc | 2,456,466 | 291.6M $ | 4.94 % |
| 5 | Gilead Sciences Inc | 1,841,333 | 247.5M $ | 4.19 % |
| 6 | AbbVie Inc | 1,068,019 | 232.5M $ | 3.94 % |
| 7 | Amgen Inc | 590,203 | 198.8M $ | 3.37 % |
| 8 | Thermo Fisher Scientific Inc | 362,337 | 178.5M $ | 3.02 % |
| 9 | Vertex Pharmaceuticals Inc | 361,907 | 162M $ | 2.74 % |
| 10 | Pfizer Inc | 5,899,018 | 154.4M $ | 2.61 % |
| 11 | Edwards Lifesciences Corp | 1,710,975 | 147.9M $ | 2.51 % |
| 12 | Danaher Corp | 645,138 | 117.8M $ | 2.00 % |
| 13 | Abbott Laboratories | 1,361,894 | 116.6M $ | 1.97 % |
| 14 | Intuitive Surgical Inc | 271,432 | 115.3M $ | 1.95 % |
| 15 | Teva Pharmaceutical Industries Ltd | 3,121,339 | 110.2M $ | 1.87 % |
| 16 | Boston Scientific Corp | 1,945,032 | 94M $ | 1.59 % |
| 17 | Elevance Health Inc | 234,947 | 92.4M $ | 1.56 % |
| 18 | Argenx SE | 88,995 | 74.4M $ | 1.26 % |
| 19 | Biogen Inc | 364,188 | 71.4M $ | 1.21 % |
| 20 | AstraZeneca PLC | 384,355 | 71.4M $ | 1.21 % |
| 21 | Stryker Corp | 221,948 | 67.7M $ | 1.15 % |
| 22 | REVOLUTION MEDICINES INC | 361,340 | 56.9M $ | 0.96 % |
| 23 | Humana Inc | 178,205 | 54.4M $ | 0.92 % |
| 24 | Regeneron Pharmaceuticals Inc | 87,659 | 53.9M $ | 0.91 % |
| 25 | Bristol-Myers Squibb Co | 917,026 | 52.4M $ | 0.89 % |
| 26 | COGENT BIOSCIENCES INC | 1,406,858 | 49.2M $ | 0.83 % |
| 27 | Dexcom Inc | 663,769 | 48.9M $ | 0.83 % |
| 28 | Waters Corp | 124,449 | 47.7M $ | 0.81 % |
| 29 | CYTOKINETICS INC | 575,188 | 44.2M $ | 0.75 % |
| 30 | Penumbra Inc | 133,216 | 42.4M $ | 0.72 % |
| 31 | HCA Healthcare Inc | 111,627 | 42.3M $ | 0.72 % |
| 32 | Insmed Inc | 392,149 | 41.9M $ | 0.71 % |
| 33 | CVS Health Corp | 459,705 | 41.8M $ | 0.71 % |
| 34 | Rhythm Pharmaceuticals Inc | 471,276 | 41.6M $ | 0.70 % |
| 35 | Galderma Group AG | 188,090 | 39.8M $ | 0.67 % |
| 36 | Incyte Corp | 396,174 | 38.3M $ | 0.65 % |
| 37 | Novartis AG | 251,660 | 37.8M $ | 0.64 % |
| 38 | Protagonist Therapeutics Inc | 370,408 | 36.9M $ | 0.62 % |
| 39 | Agilent Technologies Inc | 271,239 | 36.8M $ | 0.62 % |
| 40 | IDEXX Laboratories Inc | 65,102 | 36.7M $ | 0.62 % |
| 41 | Nuvalent Inc | 315,841 | 34.9M $ | 0.59 % |
| 42 | United Therapeutics Corp | 55,689 | 31M $ | 0.53 % |
| 43 | ALNYLAM PHARMACEUTICALS INC | 94,913 | 28.7M $ | 0.49 % |
| 44 | Bruker Corp | 471,949 | 27.8M $ | 0.47 % |
| 45 | MODERNA INC | 560,799 | 26.5M $ | 0.45 % |
| 46 | IQVIA Holdings Inc | 141,190 | 25.7M $ | 0.44 % |
| 47 | Illumina Inc | 145,933 | 23.8M $ | 0.40 % |
| 48 | Medline Inc | 605,149 | 22.1M $ | 0.37 % |
| 49 | Apogee Therapeutics Inc | 263,702 | 21.7M $ | 0.37 % |
| 50 | McKesson Corp | 27,586 | 20.5M $ | 0.35 % |
| 51 | BioMarin Pharmaceutical Inc | 322,635 | 18.5M $ | 0.31 % |
| 52 | Neurocrine Biosciences Inc | 113,005 | 17.9M $ | 0.30 % |
| 53 | Dianthus Therapeutics Inc | 186,482 | 17.3M $ | 0.29 % |
| 54 | Roivant Sciences Ltd | 563,855 | 16.9M $ | 0.29 % |
| 55 | Quest Diagnostics Inc | 85,193 | 16.6M $ | 0.28 % |
| 56 | LB Pharmaceuticals Inc | 567,627 | 15.9M $ | 0.27 % |
| 57 | UCB SA | 53,577 | 15.7M $ | 0.27 % |
| 58 | ORUKA THERAPEUTICS INC | 264,813 | 15.5M $ | 0.26 % |
| 59 | Stoke Therapeutics Inc | 473,152 | 14.6M $ | 0.25 % |
| 60 | ARCUS BIOSCIENCES INC | 572,430 | 14.5M $ | 0.25 % |
| 61 | Madrigal Pharmaceuticals Inc | 27,588 | 13.7M $ | 0.23 % |
| 62 | IONIS PHARMACEUTICALS INC | 170,008 | 13M $ | 0.22 % |
| 63 | Cencora Inc | 46,310 | 12.5M $ | 0.21 % |
| 64 | Exelixis Inc | 231,652 | 11.7M $ | 0.20 % |
| 65 | ELANCO ANIMAL HEALTH INC | 483,249 | 11.5M $ | 0.20 % |
| 66 | Daiichi Sankyo Co Ltd | 673,800 | 11.3M $ | 0.19 % |
| 67 | Scholar Rock Holding Corp | 226,209 | 11.2M $ | 0.19 % |
| 68 | Kailera Therapeutics Inc | 464,174 | 10.6M $ | 0.18 % |
| 69 | West Pharmaceutical Services Inc | 32,517 | 10.5M $ | 0.18 % |
| 70 | MBX BIOSCIENCES INC | 333,350 | 10.5M $ | 0.18 % |
| 71 | NATERA INC | 46,190 | 10.3M $ | 0.17 % |
| 72 | Charles River Laboratories International Inc | 56,177 | 10.2M $ | 0.17 % |
| 73 | Bio-Techne Corp | 193,925 | 10M $ | 0.17 % |
| 74 | Novocure Ltd | 574,295 | 9.8M $ | 0.17 % |
| 75 | Intellia Therapeutics Inc | 664,846 | 9.4M $ | 0.16 % |
| 76 | Erasca Inc | 709,864 | 9.1M $ | 0.15 % |
| 77 | VIRIDIAN THERAPEUTICS INC | 516,095 | 9.1M $ | 0.15 % |
| 78 | Glaukos Corp | 87,150 | 9M $ | 0.15 % |
| 79 | Axsome Therapeutics Inc | 38,178 | 9M $ | 0.15 % |
| 80 | Bright Minds Biosciences Inc | 95,655 | 8.4M $ | 0.14 % |
| 81 | Agios Pharmaceuticals Inc | 271,615 | 8M $ | 0.14 % |
| 82 | Eikon Therapeutics Inc | 722,389 | 7.8M $ | 0.13 % |
| 83 | VAXCYTE INC | 147,352 | 7.6M $ | 0.13 % |
| 84 | Mettler-Toledo International Inc | 6,058 | 7.2M $ | 0.12 % |
| 85 | Enanta Pharmaceuticals Inc | 492,001 | 6.5M $ | 0.11 % |
| 86 | ALUMIS INC | 293,662 | 6.3M $ | 0.11 % |
| 87 | Immunome Inc | 288,792 | 6.3M $ | 0.11 % |
| 88 | Monte Rosa Therapeutics Inc | 318,162 | 6.3M $ | 0.11 % |
| 89 | BridgeBio Oncology Therapeutics Inc | 673,766 | 6M $ | 0.10 % |
| 90 | PALVELLA THERAPEUTICS INC | 50,716 | 6M $ | 0.10 % |
| 91 | RadNet Inc | 108,100 | 6M $ | 0.10 % |
| 92 | Bridgebio Pharma Inc | 86,968 | 5.8M $ | 0.10 % |
| 93 | KalVista Pharmaceuticals Inc | 212,587 | 5.7M $ | 0.10 % |
| 94 | Beam Therapeutics Inc | 168,010 | 5.5M $ | 0.09 % |
| 95 | AKTIS ONCOLOGY INC | 266,503 | 5.5M $ | 0.09 % |
| 96 | Immunocore Holdings PLC | 188,691 | 5.5M $ | 0.09 % |
| 97 | DYNE THERAPEUTICS INC | 278,934 | 5.4M $ | 0.09 % |
| 98 | Denali Therapeutics Inc | 251,859 | 5.3M $ | 0.09 % |
| 99 | Maze Therapeutics Inc | 184,453 | 4.9M $ | 0.08 % |
| 100 | Summit Therapeutics Inc | 276,987 | 4.9M $ | 0.08 % |
Sector breakdown
- Health care 82.8 %
- Unattributed 17.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 97.6 %
- GBP 1.2 %
- CHF 0.7 %
- EUR 0.3 %
- JPY 0.2 %
- DKK 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 93.5 %
- Israel 1.9 %
- Netherlands 1.3 %
- United Kingdom 1.2 %
- Switzerland 0.8 %
- Bermuda 0.3 %
- Belgium 0.3 %
- Japan 0.2 %
- Jersey 0.2 %
- Canada 0.1 %
- Germany 0.1 %
- British Virgin Islands 0.1 %
- Other countries 0.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 117 | 5.4B $ | 93.48 % |
| 2 | Israel | 1 | 110.2M $ | 1.89 % |
| 3 | Netherlands | 1 | 74.4M $ | 1.28 % |
| 4 | United Kingdom | 1 | 71.4M $ | 1.22 % |
| 5 | Switzerland | 2 | 44.1M $ | 0.76 % |
| 6 | Bermuda | 1 | 16.9M $ | 0.29 % |
| 7 | Belgium | 2 | 16.7M $ | 0.29 % |
| 8 | Japan | 1 | 11.3M $ | 0.19 % |
| 9 | Jersey | 1 | 9.8M $ | 0.17 % |
| 10 | Canada | 1 | 8.4M $ | 0.14 % |
| 11 | Germany | 1 | 4M $ | 0.07 % |
| 12 | British Virgin Islands | 1 | 3.8M $ | 0.07 % |
Cite this page
Titelia. "Holdings of BlackRock Health Sciences Opportunities Portfolio". https://titelia.com/en/funds/S000001877